Healthcare and Life Science
Cambridge & Huntingdon based property firm Rapleys makes biggest acquisition in 72 years
London, UK - Rapleys announces it has welcomed London surveying firm Aston Rose into its business, the biggest single expansion in the partnership's 72 year history. The property consultancy has been on a strategic growth drive in recent months having onboarded planning practice CSJ in ...
Anne Glover and Hermann Hauser, reflecting on 25 years of Amadeus Capital Partners
As Amadeus celebrates 25 years since it was founded, Partner Amelia Armour sits down with Hermann Hauser and Anne Glover to reflect on the past three decades in our latest podcast episode. ...
The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein
Antigen designed to support immunoassay and vaccine development applications
Leading UK Diagnostics provider Source LDPath expands AI capabilities with Ibex Medical Analytics
NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency ...
Metrion Biosciences and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation ...
Owlstone Medical launches Breath Biopsy VOC Atlas
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the launch of the Breath Biopsy VOC Atlas, a catalogue of validated and quantitated volatile organic compounds (VOCs) found on breath. T...
Sync Neural Synchronised Impact fund: the ultimate investment vehicle to save the world?
London & Cambridge (UK) and Lucerne (Switzerland) - Sync Neural, the Swiss based holding company that addresses carbon neutrality, has signed a product partnership agreement with AlgoDynamix, the leader in behavioural-based price forecasting for financial markets. New investment pro...
Shenandoah Biotechnology introduces expanded range of CTGrade recombinant proteins manufactured following cGMP practices
Shenandoah Biotechnology Inc., a FUJIFILM Irvine Scientific company and leading manufacturer of recombinant proteins, today announced it has expanded its CTGrade portfolio of cytokines and growth factors for cell and gene therapies manufactured following cGMP guidelines. The expanded ra...
Mitigating risk: A conversation with Biocair's Sarah Pentney
Sarah Pentney, Biocair’s Global Quality and Compliance Manager, discusses how to stay up-to-date on the regulatory landscape and what is involved in mitigating risk when shipping Active Pharmaceutical Ingredients (APIs) and finished drug products. ...
Biocair announces event to advise on building a resilient supply chain
Biocair is aiming to educate Contract Manufacturing Organisations (CMOs) and pharmaceutical sponsors on the value of lane risk assessments ahead of shipping Active Pharmaceutical Ingredients (APIs) and finished drug products globally. ...